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Summary
Neutropenia associated with race/ethnicity has essentially been unexplained
and, although thought to be benign, may affect therapy for cancer or other
illnesses. A recent study linked a single nucleotide polymorphism (SNP)
(rs2814778) in the Duffy antigen/receptor chemokine gene (DARC) with
white blood cell count. We therefore analysed the association of the
rs2814778 CC, TC and TT genotypes with absolute neutrophil count (ANC)
among asymptomatic women from the Caribbean, Europe and the United
States. Among 261 study participants, 33/47 women from Barbados/
Trinidad-Tobago, 34/49 from Haiti, 26/37 from Jamaica, and 29/38 US-
born black women, but only 4/50 from the Dominican Republic and 0/40
US- or European-born whites (P = 0Æ0001) had the CC genotype. In a linear
regression model that included percentage African ancestry, national origin,
cytokines, socio-economic factors and the ELA2 rs57834246 SNP, only the
DARC rs2814778 genotype and C-reactive protein were associated with ANC
(P < 0Æ0001). Women with the CC genotype had lower ANC than other
women. Further research is needed on the associations of rs2814778 genotype
with neutropenia and treatment delay in the setting of cancer. A better
understanding of these associations may help to improve cancer outcomes
among individuals of African ancestry.
Keywords: ethnic neutropenia, chemokines, DARC, African descent, geno-
type CC.
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About 25–40% of blacks in the United States are neutropenic;
neutropenia is also prevalent in African and Afro-Caribbean
populations (Siebers et al, 1989; Bain, 1996; Haddy et al, 1999;
Bain et al, 2000; Hsieh et al, 2007; Grann et al, 2008). Previous
studies comparing Afro-Caribbean and African immigrants to
people of African descent born in the United Kingdom found
that both groups had similar white blood cell counts (WBC)
and absolute neutrophil counts (ANC) and that both groups’
counts were lower than those of UK-born people of European
descent. A study of white blood cell response to running a
marathon, a reflection of release of neutrophils from bone
marrow stores in response to cortisol, showed that runners of
African ancestry had a smaller increase in WBC and ANC than
white or Asian runners (Bain et al, 2000). The WBC response
to brief intense exercise, which reflects neutrophil demargin-
ation in response to catecholamine release, has also been found
to be lower in people of African descent than in those of
European descent (Phillips et al, 2000). Diet, lifestyle and
geographic location appear unlikely to explain the racial
differences in leucocyte measures (Bain, 1996), but their
biological causes are also not understood.
We recently found that women of African descent with
early-stage breast cancer had lower baseline WBC and longer
duration of adjuvant chemotherapy than non-Hispanic white
women (Hershman et al, 2003). Black women were more likely
to miss cycles of chemotherapy and had poorer survival than
white women. These observations raised questions about
whether the prevalence of low WBC varied among ethnic
subgroups and how WBC might be related to other biomarkers
among women without cancer. Such biomarkers might also
help to identify patients with sickle cell disease who would be
at increased risk for neutropenia during treatment with
hydroxycarbamide (hydroxyurea) (Brawley et al, 2008).
The gene that controls expression of the Duffy antigen
receptor for chemokines (DARC), located on chromosome 1,
has long been known to be associated with race. Within the
gene, the single nucleotide polymorphism (SNP) most strongly
associated with race is DARC rs2814778 (Nalls et al, 2008).
The CC genotype is present among 70–75% of blacks and is
rare among whites in the United States. Among individuals
with the CC genotype, DARC is not expressed (http://
www.utdol.com/utd/content/topic.do?topicKey=transfus/11818
&view=text). The same genotype was also recently reported to
be associated with low WBC (Nalls et al, 2008).
We analysed the association of DARC rs2814778 genotype
with WBC and ANC, as well as other factors thought to be
associated with WBC, in an ethnically diverse sample of
women without serious illness.
Patients and methods
Study design
For this cross-sectional study, we recruited women aged 20–
70 years who identified themselves as coming from the United
States (US) or one of the Caribbean countries of origin chosen
for analysis: Barbados/Trinidad-Tobago, the Dominican
Republic, Haiti, and Jamaica. US-born women were eligible
if they were either black and had US-born parents, or white.
For statistical purposes based on power calculations, we aimed
to recruit 40 subjects per ethnic group. Participants repre-
sented a convenience sample recruited at Columbia University
Medical Center in upper Manhattan or Long Island University
in Brooklyn.
Women were screened for enrolment according to place of
birth, age at immigration, primary language, current age and
medical history. Women who reported a specific illness or
disease-related symptoms were excluded from the study.
After obtaining informed consent, we asked the study
participants to respond to a questionnaire about demographic
and behavioural factors and health history and to provide a
blood specimen. A phlebotomist performed venipuncture to
obtain a 10 ml blood sample in a yellow-top tube (citrate).
Subjects received financial compensation for their participa-
tion. Between October 2003 and February 2006, 276 women
were enrolled; 13 were excluded because their questionnaire
was lost, their blood sample had clotted, or their country of
origin was not one of those included in the study; two were
excluded because of human immunodeficiency virus infection.
Laboratory procedures
The Herbert Irving Comprehensive Cancer Center (HICCC)
Biomarker Shared Resource and special hematology laboratory
at Columbia University Medical Center performed all the
analyses except for genotyping. The complete blood counts
were determined by SysmexTM Automated Hematology Ana-
lyzer XE-2100. Tumour necrosis factor-alpha (TNF-a) levels
were measured with the Human TNF-a/TNFSF1A Immuno-
assay kit (Quantikine HS; R&D Systems, Minneapolis, MN,
USA), granulocyte colony-stimulating factor (G-CSF) levels
with the G-CSF Immunoassay kit (Quantikine HS), granulo-
cyte macrophage-colony stimulating factor (GM-CSF) levels
using the GM-CSF Immunoassay kit (Quantikine HS), and
C-reactive protein (CRP) levels with the High Sensitivity CRP
Enzyme Immunoassay Test kit (Life Diagnostics, Inc., West
Chester, PA, USA). All immunoassays were performed in
duplicate, according to manufacturers’ instructions (Grann
et al, 2008).
ELA2 polymorphisms (Horwitz et al, 2007) were detected by
Sanger dideoxy DNA sequencing of genomic DNA. Polymor-
phisms indicative of African ancestry, including the rs2814778
SNP, were analyzed using the Sequenom MassARRAY plat-
form and iPLEX Gold chemistry at the Children’s Hospital of
Oakland Research Institute (CHORI) Functional Genomics
Core (Maglott et al, 2007; Wassel Fyr et al, 2007; Nalls et al,
2008). The MassARRAY platform utilized multiplexed (up to
36-plex) polymerase chain reaction-based target amplification/
single-base extension (SBE) coupled with allelic discrimination
based on mass differences of SBE products. Detection of mass
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spectra was achieved with Matrix Assisted Laser Desorption/
Ionization Time-of-Flight mass spectrometry.
Individual genetic ancestry was estimated by a maximum
likelihood approach (Tang et al, 2005).
Statistical analysis
The frequency distribution of the rs2814778 genotypes (CC,
TC, or TT) was analysed by national origin, median ANC,
cytokine (TNF-a, G-CSF and CRP) levels, and ELA2 rs5784246
genotypes (CC, CA, or AA) using chi-square, Fisher’s exact,
and Kruskal–Wallis tests. We also analysed the correlation of
ANC with African ancestry. The same variables were then
included in a linear regression model with log-transformed
ANC as the dependent variable. We set the statistical
significance criterion as two-sided P £ 0Æ05.
Results
Of the 261 women (Table I) who provided data for the
analyses, 47 came from Barbados or Trinidad-Tobago, 50 from
the Dominican Republic, 49 from Haiti, 37 from Jamaica, 75
from the United States (38 black and 37 white), and three from
Europe (grouped with the US-born whites). The six study
groups were similar with respect to age by Kruskal–Wallis test.
Of the 183 study participants of Caribbean origin, only 25
(13Æ7%) were US-born (one whose parents came from
Barbados, 14 from the Dominican Republic, four from Haiti
and six from Jamaica).
For the total sample of 261 women, the mean and median
WBC were 6548 · 109/l and 6200 · 109/l respectively; the
mean and median ANC were 3671 · 109/l and 3306 · 109/l.
The DARC rs2814778 genotypes were strongly associated
with national origin (Table I). No US-born white women and
only four Dominican women (8%) had the CC genotype
(overall P = 0Æ0001). Women with the CC genotype had lower
median ANC (P < 0Æ0001) and higher G-CSF (P = 0Æ002), and
were more likely to have the ELA2 rs57834246 genotype
(P < 0Æ0001) than those with the TC and TT genotypes.
The median ANC for women with the CC genotype varied
little by ethnic group (P = 0Æ91). However, the medians for
women with the TC and TT genotypes ranged from 3544
(Caucasian) to 5963 (African American) and from 3444
(Caucasian) to 5304 (Barbadian/Trinidad-Tobago) respec-
Table I. Percentage distribution of Duffy (Fy)
blood group system-associated SNPs by country
of origin, ANC, cytokines, and ELA2rs57834246
allele status.N
CC
(n = 121),
%
TC
(n = 66),
%
TT
(n = 69),
% P-value
Country (race)
Barbados/Trinidad-Tobago 45 69 20 11 0Æ0001
Dominican Republic 50 8 40 52
Haiti 49 75 25 0
Jamaica 35 63 37 0
United States (black) 37 73 27 0
United States or Europe
(white)
40 0 5 95
Overall 256 47 26 27
Median ANC (·109/l) 2684 4212 3953 <0Æ0001
% ANC £ 1500 · 109/l 4Æ4 9Æ3 0 0 0Æ001
TNF-a (pg/ml)
Non-detectable 134 48Æ5 28Æ4 23Æ1 0Æ65
£233Æ3 63 47Æ6 22Æ2 30Æ2
>233Æ3 59 44Æ1 23Æ7 32Æ2
G-CSF (ng/ml)
<0Æ0259 85 32Æ9 27Æ1 40Æ0 0Æ002
0Æ026–0Æ0381 82 47Æ6 24Æ4 28Æ0
>0Æ0381 84 59Æ5 26Æ2 14Æ3
CRP (lg/ml)
<1Æ54 116 44Æ0 25Æ9 30Æ2 0Æ84
1Æ55–5Æ67 66 29Æ3 22Æ7 25Æ8
>5Æ67 64 46Æ9 28Æ1 25Æ0
ELA2 rs57834246 genotype
CC 168 36Æ3 25Æ6 38Æ1 0Æ0001
CA or AA 75 69Æ3 24Æ0 6Æ7
ANC, absolute neutrophil count; SNPs, single nucleotide polymorphisms; CRP, C-reactive
protein; G-CSF, granulocyte colony-stimulating factor; TNF-a, tumour necrosis factor-alpha.
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tively (Fig 1). Because of small sample sizes, these differences
were not statistically significant (P = 0Æ08 for both TC
and TT).
In the multivariate model (Table II), only the rs2814778
genotypes and CRP were associated with ANC (P = 0Æ0001).
Discussion
These findings confirm previous observations of an association
of the DARC rs2814778 SNP with WBC (Nalls et al, 2008).
This study is, however, the first to show an association between
the SNP and low ANC and to identify the association in
subjects from the Caribbean as well as from the United States.
Our findings also suggest that the low ANC phenotype may be
recessive, given the lack of variability in ANC among women
with the CC genotype. Women with the TC and TT genotypes
had both higher and more variable ANC.
In a recent study of the same sample, clinical neutropenia
was found in 12/171 women of African descent and 0/90 white
and Dominican women with no reported explanatory medical
conditions (Grann et al, 2008). Country of origin, ELA2
rs57834246 genotype, and CRP, although not TNF-a, or
G-CSF, were associated with ANC. The addition of DARC
rs2814778 genotype to the model in the current study
eliminated all those associations except for CRP.
The association observed in the current study between
higher G-CSF and the DARC rs2814778 null homozygous
genotype may reflect a feedback mechanism stimulated by low
ANC (Semerad et al, 2002). G-CSF has been shown both to
increase neutrophil production and to accelerate neutrophil
entry into the blood (Price et al, 1996).
Individuals who lack DARC are resistant to P. vivax malaria
because the merozoite uses DARC to enter red cells (Miller
et al, 1976). Individuals who lack DARC on their red blood
cells may still express it on their postcapillary venules, where it
may interfere with leucocyte trafficking (Peiper et al, 1995;
Kashiwazaki et al, 2003; Nibbs et al, 2003).
The mechanism for the association of neutropenia with the
DARC SNP is unknown. One possibility is that individuals
who lack DARC, by which red cells absorb cytokines, are
unable to modulate white cell trafficking; hence their neu-
trophils pool and keep the circulatory ANC low. Such a
mechanism might also account for poor mobilization of white
cells in response to exercise and stress (Phillips et al, 2000;
Hsieh et al, 2007). One other possibility includes a decrease of
bone marrow reserve due to a deficiency of granulocyte–
macrophage colony-forming units (Bain et al, 2000; Rezvani
et al, 2001).
Mice that were genetically engineered to lack DARC were
unable to bind CXC chemokines, which promote tumoro-
genesis and angiogenesis (Lentsch, 2006). In a small study
(n = 75) of human breast cancer pathological samples, high
DARC expressors were less likely than low DARC expressors to
have extensive lymph node metastases and had lower mortality
(Wang et al, 2006).
A limitation of this study is that it is based on a convenience
sample of women in the ethnic groups of interest. Recruitment
took longer for some groups than for others and may have
been subject to unknown biases. However, it is difficult to see
how bias could account for the association observed between
ANC and genotype, neither of which could have been known
to the study participants or us prior to the analysis.
Another limitation is that the WBC and ANC were analysed
in healthy women. We still know nothing about the association
of neutropenia with genotype in the setting of cancer or any
other disease. However, the purpose of the study was to learn
more about the association between the study markers and
ethnicity in the absence of disease.
A third limitation is that the DARC rs2814778 genotype may
be merely a surrogate marker for another gene that is similarly
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Fig 1. Median ANC counts (x109/l) by DARC rs2814778 genotype and ethnic group. The height of each bar represents the median ANC count for
women with that genotype in that ethnic group. Above each bar are the percentage distributions of the genotypes in each ethnic group. Bar_Tri_T,
Barbados/Trinidad-Tobago; Afi-Amer, African-American.
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distributed in the populations studied. However, that SNP is
the one most strongly associated with race (Nalls et al, 2008).
Further studies may consider other candidate genes.
Conclusion
This study is the first to show an association between the
DARC rs2814778 CC genotype, common among individuals of
African descent, and low ANC. The implications of this
association for cancer patients and for those with sickle cell
disease remain to be determined. For example, whether the
effects of G-CSF as a treatment for chemotherapy-induced
neutropenia among cancer patients, and of hydroxycarbamide
as prevention for severe pain episodes among sickle cell
patients(Steinberg et al, 2003), vary by genotype needs to be
determined. Further research may help to account for and
prevent poor outcomes among persons of African ancestry and
lead to interventions that may benefit them and all patients.
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